Documentary highlights student's struggles
via abclocal.go.com
Sunday, August 30, 2009
Documentary highlights student's struggles - 8/30/09 - Chicago News - abc7chicago.com
Morgan graduate earns spot on U.S. Paralympic soccer team | zanesvilletimesrecorder.com | Zanesville Times Recorder
Morgan graduate earns spot on U.S. Paralympic soccer team
How is the Paralympic different in format than Special Olympics?
Saturday, August 29, 2009
Robots may soon be serving the elderly at home just like humans do
Elderly people with limited mobility may soon come to be served by robots in a manner as if they are being served by other persons, thanks to a collaborative study by three University of Illinois at Chicago engineers and a Rush University nursing specialist.
“We want to help elderly people communicate with robots, to tell them what they need, and to perform physical activities,” said Milos Zefran, UIC associate professor of electrical and computer engineering.
The three-year study, supported by a grant of 989,000 dollars from the National Science Foundation, is aimed at developing software to allow the elderly to communicate with robots that can respond to a wide range of verbal language, non-verbal gestures, and touch.
“If we can help the elderly remain independent and continue living in their own homes, that will improve their health outlook while relieving the burden on family members and health care providers,” said Zefran, the lead researcher.
The researchers say that their communication interface software will have at its core a novel adaptive and reliable recognition methodology called Recognition by Indexing and Sequencing (RISq), which will allow the robot to comprehend speech altered by impairments and to learn and adapt to such speech.
To enable a robot to understand and correctly respond to various forms of human touch, the researchers will combine techniques from natural language processing and haptics, a scientific term to describe the computerized sense of touch.
I will be following this closely. This sounds interesting.
Sunday, August 23, 2009
Saturday, August 22, 2009
Friday, August 21, 2009
Human clinical trials for stem-cell research on cards- Biotech-Healthcare / Biotech-News By Industry-News-The Economic Times - Sent using Google Toolbar
Human clinical trials for stem-cell research on cards- Biotech-Healthcare / Biotech-News By Industry-News-The Economic Times
Related articles by Zemanta
AHMEDABAD: In what is seen as a boost to the stem cell research in the country, India would soon get to host human clinical trials for therapies  Image via Wikipedia On Thursday, StemCyte announced setting up of StemCyte India Therapeutics (SCITPL), a joint venture with Ahmedabad-based pharma major Cadila Pharmaceuticals and Apollo Hospital. SCITPL will have its headquarters in Ahmedabad and the facility will be functional by the year-end. Clinical trials using UBC stemcell therapy would be carried out in three areas — thalessemia, muscular dystrophy and spinal cord injuries. Initially, the phase III trials would start for therapies to treat spinal cord injuries. The phase I & II trials have already been conducted in the US and China. While Bangalore-based Stempeutics Research recently got the clearance from the Drug Controller General of India (DCGI) to conduct trials for developing drugs using stem cells derived from the bone marrow of healthy donor, the latest move by StemCyte involves the use of UBC stem cell. Talking to ET, Dr Wise Young who is professor in Rutgers, the State University of New Jersey, said: “We had initial talks to conduct clinical trials using stem-cells derived from UBC in India. Hopefully, by the end of next year, we should begin our clinical trials here.” According to StemCyte India Therapeutics president Tushar Dalal, the three parties met in New Delhi on Wednesday and had a video conference with Apollo chairman Pratap Reddy. “Dr Reddy has expressed his willingness and would come forward to undertake this project. StemCyte would provide UBC stem cells and its technology, while Apollo Hospital would provide its infrastructure and manpower for the trials,” Mr Dalal said. A tripartite agreement is likely by this year-end, he said. Dr Young would head the trials. StemCyte has patented the plasma depletion technology that helps in collecting higher volume of stem cells and better cell counts, resulting in successful therapeutic applications for over 70 diseases. The location of the trials is significant, as India has a huge number of thalessemia patients. According to Dr Young, about 35% of the Indian population carries thalessemia genes and there is possibility of one-fourth of the children being born with the disease. | |
Zemanta helped me add links & pictures to this email. It can do it for you too.
Thursday, August 13, 2009
Crunchpad: Photos of TechCrunch's Delicious Web Tablet
The web tablet TechCrunch is working on is apparently still alive, seeing as it just showed up in Michael Arrington's posterous. UPDATED
This looks like just the right addon for my wheelchair, don't you think so?
Subscribe to:
Posts (Atom)